secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0000950170-24-099389
Event type: litigation
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome and Sandoz dismiss Sunosi patent litigation; Sandoz withdraws generic ANDA
--------------------------------------------------------------------------------

- Sandoz withdrew its ANDA for a generic equivalent of Sunosi (solriamfetol), leading to dismissal of patent litigation without prejudice.
- Litigation was pending in U.S. District Court for the District of New Jersey.
- Dismissal removes a potential near-term generic threat to Sunosi, Axsome's CNS product.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000095017024099389/0000950170-24-099389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000095017024099389/axsm-20240821.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-099389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer